N/A Completed N=50 Randomized Double-blind Other

Initial Experience With Storz C-MAC Video Intubation System

Intubation; Difficult

Source: ClinicalTrials.gov NCT01104090 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2021

Primary outcomePrimary: Time for Intubation — 12.3; 9.8 seconds

Summary

The purpose of this study is to determine the safety and efficacy of the C-MAC (Karl Storz Endoscopy, Inc., Tuttlingen, Germany) video intubation system guided intubation techniques. We hypothesize that the C-MAC video laryngoscope is safe and efficacious in terms of successful endotracheal intubation. The C-MAC may be a safe and suitable alternative device for routine and difficult laryngoscopy and tracheal intubation. This is the first study to investigate the performance of C-MAC in clinical practice.

Outcome Measures

Outcome	Result	p-value
PRIMARY Time for Intubation	12.3; 9.8	—
SECONDARY Laryngoscopy Time	8.7; 14.1; 9.1; 12.2	—
SECONDARY Airway View at the Time of Laryngoscopy as Categorized by the Modified Cormack-Lehane Classification (Before External Manipulation)	12; 19; 7; 3; 6; 1	—
SECONDARY Airway View at the Time of Laryngoscopy as Categorized by the Modified Cormack-Lehane Classification (After External Manipulation)	15; 20; 10; 4; 0; 1	—
SECONDARY Number of Participants With Successful Intubation	25; 25	—
SECONDARY Ease of Intubation as Assessed by a Rating Scale	14; 16; 6; 4; 4; 4	—
SECONDARY Ease of Laryngoscopy as Assessed by a Rating Scale	15; 13; 5; 4; 4; 5	—

Eligibility Criteria

Inclusion Criteria

Age 18 - 80 years of age
ASA I - III
Mallampati I-III
Mouthopening > 4cm

Exclusion Criteria

Age 80 years of age
ASA IV - V
Mallampati IV - V
Mouthopening < 4cm

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01104090). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.